---
title: "Transcenta Holding (6628) stock: news and investor profile"
url: "https://aibio.space/companies/transcenta/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Transcenta Holding Limited (HKEX: 6628), China. The directory classifies it as Pharmaceuticals: Major."
---

6628 Transcenta Holding Limited HKEX · China

# Transcenta Holding (6628) news

Transcenta Holding Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6628, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Transcenta Holding news

We have not published a story on Transcenta Holding yet. When there is news, it will appear here.

## Transcenta Holding at a glance

- **Ticker**: 6628

- **Listing**: HKEX

- **Country**: China

### Related companies

- [Chongqing Taiji Industry (Group) Co.](https://aibio.space/companies/chongqing-taiji-industry/) SSE: 600129
- [Zhejiang East Asia Pharmaceutical Co.](https://aibio.space/companies/zhejiang-east-asia-pharmaceutical/) SSE: 605177
- [Zhejiang Int'l Group Co.](https://aibio.space/companies/zhejiang-int-l/) SZSE: 000411
- [HeiLongJiang ZBD Pharmaceutical Co.](https://aibio.space/companies/heilongjiang-zbd-pharmaceutical/) SSE: 603567
- [Bide Pharmatech Co.](https://aibio.space/companies/bide-pharmatech/) SSE: 688073
- [Fuan Pharmaceutical (Group) Co.](https://aibio.space/companies/fuan-pharmaceutical/) SZSE: 300194
- [Hangzhou Tianmushan Pharmaceutical Enterprise Co](https://aibio.space/companies/hangzhou-tianmushan-pharmaceutical-enterprise/) SSE: 600671
- [New Ray Medicine International Holding](https://aibio.space/companies/new-ray-medicine-international/) HKEX: 6108

### Also on HKEX

- [Beijing Luzhu Biotechnology Co.](https://aibio.space/companies/beijing-luzhu-biotechnology/) 2480
- [Laekna](https://aibio.space/companies/laekna/) 2105
- [Keymed Biosciences](https://aibio.space/companies/keymed-biosciences/) 2162
- [Vigonvita Life Sciences Co.](https://aibio.space/companies/vigonvita-life-sciences/) 2630
- [IMPACT Therapeutics](https://aibio.space/companies/impact-therapeutics/) 7630
- [B&K Corporation](https://aibio.space/companies/b-k/) 2396

## Questions about Transcenta Holding

What is the ticker symbol of Transcenta Holding?

Transcenta Holding Limited trades under the ticker 6628 on HKEX.

Where is Transcenta Holding listed?

Transcenta Holding Limited is listed on HKEX.

Which country or territory is Transcenta Holding listed under?

Our directory records Transcenta Holding Limited under China.

What does Transcenta Holding do?

Our directory classifies Transcenta Holding Limited as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Transcenta Holding?

The ISIN recorded for Transcenta Holding Limited is KYG9005B1041.

Does aibio.space cover Transcenta Holding?

aibio.space lists Transcenta Holding Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Transcenta Holding?

Companies in our directory listed in the same country and business area as Transcenta Holding: Chongqing Taiji Industry (Group) Co., Zhejiang East Asia Pharmaceutical Co., Zhejiang Int'l Group Co., HeiLongJiang ZBD Pharmaceutical Co., Bide Pharmatech Co., Fuan Pharmaceutical (Group) Co..

## Investor discussion: Transcenta Holding

Members talk about Transcenta Holding (6628). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Transcenta Holding, newest first. Each line links the filing it comes from.

1. 2026-08-24 Mergers Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS AND NOTICE OF EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500009.pdf)
2. 2026-08-06 Mergers Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0807/2026080700005.pdf)
3. 2026-07-07 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION-REVERSION OF CERTAIN LICENSED ASSETS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0707/2026070701631.pdf)
4. 2026-06-05 Financings Share or debt issue: PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED RE-APPOINTMENT OF AUDITOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES (INCLUDING SALE AND TRANSFER OF TREASURY SHARES) AND NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500419.pdf)
5. 2026-04-08 Listings Share consolidation: (1) CHANGE OF STOCK SHORT NAME; AND (2) CHANGE OF COMPANY LOGO. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0408/2026040802292.pdf)
6. 2025-09-17 Financings Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0917/2025091700564.pdf)
7. 2025-09-09 Financings Share or debt issue: PLACING OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0910/2025091000013.pdf)

## Press releases

Headlines of Transcenta Holding's own announcements, newest first. Each opens the full release on the newswire that carried it.

1. 2026-10-20 HKEXnews [VOLUNTARY ANNOUNCEMENT-RECEIPT OF THE FIRST PAYMENT IN RELATION TO THE DISPOSAL OF CDMO ASSETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1020/2026102000289.pdf)
2. 2026-10-12 HKEXnews [VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON THE GRANT OF CHINA INVENTION PATENTS RELATED TO OSEMITAMAB (TST001) AND ITS COMPANION DIAGNOSTIC ANTIBODY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1012/2026101200051.pdf)
3. 2026-09-30 HKEXnews [CANCELLATION AND GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093002393.pdf)
4. 2026-09-15 HKEXnews [NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0915/2026091500330.pdf)
5. 2026-09-15 HKEXnews [NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0915/2026091500314.pdf)
6. 2026-09-09 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, SEPTEMBER 9, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0909/2026090901181.pdf)
7. 2026-08-28 HKEXnews [(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) COMPLIANCE WITH RULE 3.10(1) OF THE LISTING RULES; AND (3) GRANT OF AWARD PURSUANT TO THE SHARE INCENTIVE SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082804228.pdf)
8. 2026-08-28 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082803004.pdf)
9. 2026-08-24 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html)
10. 2026-08-24 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500011.pdf)
11. 2026-08-24 HKEXnews [MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500009.pdf)
12. 2026-08-21 HKEXnews [CLOSURE OF REGISTER OF MEMBERS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082100660.pdf)
13. 2026-08-06 HKEXnews [MAJOR TRANSACTION DISPOSAL OF CDMO ASSETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0807/2026080700005.pdf)
14. 2026-07-27 HKEXnews [UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0728/2026072800033.pdf)
15. 2026-07-27 HKEXnews [(1) CHANGE IN THE COMPOSITION OF BOARD COMMITTEES; AND (2) UPDATE ON COMPLIANCE STATUS IN RELATION TO RULES 3.10(1), 3.21 AND 3.27A OF THE LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0727/2026072701373.pdf)
16. 2026-07-07 HKEXnews [DISCLOSEABLE TRANSACTION-REVERSION OF CERTAIN LICENSED ASSETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0707/2026070701631.pdf)
17. 2026-06-30 HKEXnews [GRANT OF AWARD SHARES AND OPTIONS PURSUANT TO THE SHARE INCENTIVE SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003919.pdf)
18. 2026-06-30 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 30, 2026; (2) CHANGE OF DIRECTORS AND COMPOSITION OF BOARD COMMITTEES; AND (3) NON-COMPLIANCE WITH RULES 3.10(1), 3.21 AND 3.27A OF THE LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063002465.pdf)
19. 2026-06-05 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500539.pdf)
20. 2026-06-05 HKEXnews [PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED RE-APPOINTMENT OF AUDITOR AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY-BACK SHARES AND TO ISSUE SHARES (INCLUDING SALE AND TRANSFER OF TREASURY SHARES) AND NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060500419.pdf)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6628 on TradingView](https://www.tradingview.com/symbols/HKEX-6628/).

## Listing details

Transcenta Holding Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 6628, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Transcenta Holding Limited

- **Ticker**: 6628

- **Listing**: HKEX

- **Country or territory**: China

- **Business scope**: Pharmaceuticals: Major

- **ISIN**: KYG9005B1041

- **Last quote in directory**: 2026-10-22

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6628/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/transcenta/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Transcenta Holding (6628) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/transcenta/
